Katie O’Callaghan

1.1k citations

19 papers · 904 indexed · h-index 11

Molecular Biology
Hematology top 5%
Cancer Research top 10%
Oncology
Cellular and Molecular Neuroscience top 10%

Co-authors: Lidija Covic Athan Kuliopulos Adrienne Boire Nicole C. Kaneider Eric Yang Anika Agarwal Nga Nguyen Boris Tchernychev
Topics: Blood Coagulation and Thrombosis Mechanisms (5 papers)CAR-T cell therapy research (4 papers)Multiple Myeloma Research and Treatments (4 papers)
Cited by: Hematology Cancer Research Genetics
Journals: Cell Journal of Biological Chemistry Circulation
Partner nations: United States Ireland Italy

In The Last Decade

Katie O’Callaghan

19 papers receiving 892 citations

Peers

Countries citing papers authored by Katie O’Callaghan

Since Specialization

Citations

This map shows the geographic impact of Katie O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie O’Callaghan more than expected).

Fields of papers citing papers by Katie O’Callaghan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie O’Callaghan. The network helps show where Katie O’Callaghan may publish in the future.

Co-authorship network of co-authors of Katie O’Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Katie O’Callaghan. A scholar is included among the top collaborators of Katie O’Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie O’Callaghan. Katie O’Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Abstract LB360: Discovery and development of fully human IL13Ra2/B7H3 bispecific armored CAR-T for treatment of glioblastoma 2025 ·Cancer Research ·Keming Zhang,(unknown),Katie O’Callaghan,(unknown),(unknown),(unknown),(unknown),(unknown),Yan Chen	1
2	Abstract LB188: Discovery and development of fully human TACI/BCMA bispecific armored CAR for the treatment of relapsed/refractory multiple myeloma 2023 ·Cancer Research ·(unknown),(unknown),Katie O’Callaghan,Keming Zhang,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Yan Chen	1
3	Abstract P216: IK-930 mediated TEAD inhibition decreases and delays tumor growth and enhances targeted apoptosis in lung and colon cancer xenografts when combined with MEK or EGFR inhibitors 2021 ·Molecular Cancer Therapeutics ·Benjamin Amidon,(unknown),(unknown),Jill Cavanaugh,(unknown),Katie O’Callaghan,P Natarajan,Jeffrey Ecsedy,Karen McGovern,Alfredo Castro	7
4	448 Discovery of clinical candidate IK-175, a selective orally active AHR antagonist 2020 ·Regular and Young Investigator Award Abstracts ·Karen McGovern,Alfredo Castro,Jill Cavanaugh,(unknown),Jeremy H. Tchaicha,(unknown),(unknown),P Natarajan,Katie O’Callaghan,(unknown),(unknown),(unknown)	3
5	Adaptability of Antibody-Coupled T Cell Receptor (ACTR) Engineered Autologous T Cells in Combination with Daratumumab over CAR-Based Approaches 2017 ·Blood ·(unknown),(unknown),Katie O’Callaghan,(unknown),(unknown),Allison Nelson,Greg Motz,Jessica Sachs,Birgit C. Schultes,Seth A. Ettenberg,Tooba A. Cheema	2
6	Abstract 4605: Efficient targeting of BCMA-positive multiple myeloma cells by antibody-coupled T-cell receptor (ACTR) engineered autologous T cells in combination with an anti-BCMA antibody 2017 ·Cancer Research ·Tooba A. Cheema,(unknown),Katie O’Callaghan,Lori Westendorf,Luke S. Manlove,Shyra J. Gardai,Allison Nelson,(unknown),Kathleen E. McGinness,Birgit C. Schultes,Seth A. Ettenberg,Django Sussman,Heather Huet	1
7	Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2 2015 ·Oncogene ·Eric Yang,Jarosław Cisowski,Nga Nguyen,Katie O’Callaghan,Jian Xu,Anika Agarwal,Athan Kuliopulos,Lidija Covic	43
8	IMGN529, a Novel Antibody-Drug Conjugate (ADC) Targeting CD37 Shows Synergistic Activity with Rituximab in Non-Hodgkin Lymphoma (NHL) Models 2015 ·Blood ·Jutta Deckert,Callum M. Sloss,Katie O’Callaghan,(unknown),(unknown),Yong Weon Yi,Jennifer A. Coccia,Leanne Lanieri,(unknown),Angela Romanelli	3
9	HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer 2014 ·PLoS ONE ·Brenda O’Connell,Katie O’Callaghan,Bonnie Tillotson,Mark Douglas,Nafeeza Hafeez,Kip A. West,Howard M. Stern,Janid A. Ali,Paul S. Changelian,Christian Fritz,Vito J. Palombella,Karen McGovern,Jeffery L. Kutok	14
10	Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development 2012 ·Journal of Biological Chemistry ·Katie O’Callaghan,Athan Kuliopulos,Lidija Covic	125
11	Suppression of Arterial Thrombosis Without Affecting Hemostatic Parameters With a Cell-Penetrating PAR1 Pepducin 2012 ·Circulation ·Ping Zhang,András Gruber,Shogo Kasuda,Carey Kimmelstiel,Katie O’Callaghan,Daniel H. Cox,Andrew Bohm,James Baleja,Lidija Covic,Athan Kuliopulos	62
12	Matrix Metalloprotease-1a Promotes Tumorigenesis and Metastasis 2012 ·Journal of Biological Chemistry ·Caitlin Foley,Chi Luo,Katie O’Callaghan,Philip W. Hinds,Lidija Covic,Athan Kuliopulos	46
13	Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer 2011 ·American Journal Of Pathology ·Jarosław Cisowski,Katie O’Callaghan,Athan Kuliopulos,John Yang,Nga Nguyen,Qing Deng,Eric Yang,Michael Fogel,Sarah L. Tressel,Caitlin Foley,Anika Agarwal,S. Hunt,(unknown),(unknown),Lidija Covic	75
14	Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia 2011 ·Blood ·Katie O’Callaghan,Lydia Lee,Nga Nguyen,(unknown),Nicole C. Kaneider,Andreas K. Klein,Kellie Sprague,Richard A. Van Etten,Athan Kuliopulos,Lidija Covic	52
15	Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis 2009 ·Cancer Research ·Eric Yang,Adrienne Boire,Anika Agarwal,Nga Nguyen,Katie O’Callaghan,Powen Tu,Athan Kuliopulos,Lidija Covic	121
16	Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site 2009 ·Cell ·Vishal Trivedi,Adrienne Boire,Boris Tchernychev,Nicole C. Kaneider,Andrew J. Leger,Katie O’Callaghan,Lidija Covic,Athan Kuliopulos	190
17	Heme-binding Protein HRG-1 Is Induced by Insulin-like Growth Factor I and Associates with the Vacuolar H+-ATPase to Control Endosomal pH and Receptor Trafficking 2009 ·Journal of Biological Chemistry ·Katie O’Callaghan,Verónica Ayllón,(unknown),Yanru Wang,Órla T. Cox,Gary Loughran,Michael Forgac,Rosemary O’Connor	55
18	CXCR4 Pepducins in Stem Cell Mobilization. 2009 ·Blood ·Katie O’Callaghan,(unknown),(unknown),Lidija Covic,Athan Kuliopulos	2
19	The Insulin-like Growth Factor-I–mTOR Signaling Pathway Induces the Mitochondrial Pyrimidine Nucleotide Carrier to Promote Cell Growth 2007 ·Molecular Biology of the Cell ·Suzanne Floyd,Cédric Favre,Francesco M. Lasorsa,Madeline Leahy,Giuseppe Trigiante,Philipp Stroebel,Alexander Marx,Gary Loughran,Katie O’Callaghan,C Marobbio,Dirk Jan Slotboom,Edmund R.S. Kunji,Ferdinando Palmieri,Rosemary O’Connor	101

About Katie O’Callaghan

Katie O’Callaghan is a scholar working on Hematology, Immunology and Allergy and Biological Psychiatry, having authored 19 papers that have together received 904 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (5 papers), CAR-T cell therapy research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Hematology (301 citations), Cancer Research (223 citations) and Genetics (113 citations). Katie O’Callaghan has collaborated with scholars based in United States, Ireland and Italy. Frequent co-authors include Lidija Covic, Athan Kuliopulos, Adrienne Boire, Nicole C. Kaneider, Eric Yang, Anika Agarwal, Nga Nguyen, Boris Tchernychev, Andrew J. Leger and Vishal Trivedi. Their work appears in journals such as Cell, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact